Browsing HV - Fakultet for helsevitenskap ansatte by Author "Rose, Christopher James"
Now showing items 1-3 of 3
-
Effect modification in network meta-analyses for relapsed/refractory multiple myeloma: Systematic review and meta-analysis
Rose, Christopher James; Ohm, Ingrid Kristine; Giske, Liv; Næss, Gunn Eva; Fretheim, Atle (Peer reviewed; Journal article, 2023)Objectives To systematically review and meta-analyse the evidence for effect modification by refractory status and number of treatment lines in relapsed/refractory multiple myeloma (RRMM); and to assess whether ... -
Informed Health Choices media intervention for improving people’s ability to critically appraise the trustworthiness of claims about treatment effects: a mixed-methods process evaluation of a randomised trial in Uganda
Semakula, Daniel; Nsangi, Allen; Oxman, Andrew David; Glenton, Claire; Lewin, Simon Arnold; Rosenbaum, Sarah Ellen; Oxman, Matt; Kaseje, Margaret; Dahlgren, Astrid; Rose, Christopher James; Fretheim, Atle; Sewankambo, Nelson (BMJ Open;Volume 9, Issue 12, Journal article; Peer reviewed, 2019-10-29)We developed the Informed Health Choices podcast to improve people’s ability to assess claims about the effects of treatments. We evaluated the effects of the podcast in a randomised trial. Objectives We conducted this ... -
Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission
Kvist, Beate Charlotte Fagerlund; Chudasama, Kishan Kumar; Brurberg, Kjetil Gundro; Robberstad, Bjarne; Rose, Christopher James; Juvet, Lene Kristine; Fretheim, Atle (Book; Peer reviewed; Research report, 2019-08-16)Breast cancer can be treated with chemotherapy, hormone therapy and radiation, or a combination of these to prevent the spread of cancer cells, after surgical removal of the tumor. When assessing whether a patient should ...